Park Ha Biological Technology Co., Ltd.

Park Ha Biological Technology Co., Ltd. has elected to rely on the Nasdaq home country practice exemption under Rule 5615(a)(3). As a company incorporated in the Cayman Islands, this allows it to follow its home country corporate governance practices in lieu of certain Nasdaq requirements. These exemptions include rules regarding the composition of the board of directors, distribution of reports, and shareholder approval for various securities issuances and changes to voting rights.